Kimryn Rathmell: Telomere biology and cancer risk
Kimryn Rathmell shared a post by National Cancer Institute on X:
“Sharing an oldie but a goodie.
If you want to learn more about telomere biology, cancer risk, and the fantastic research National Cancer Institute scientists are conducting in this space, I invite you to check out this video.”
Quoting National Cancer Institute‘s post:
“It’s Telomere Biology Disorder Awareness month.
Telomeres are the ends of chromosomes.
National Cancer Institute scientists study telomere biology disorders that run in families and the association between very short telomeres and cancer.
Read more about telomere biology”
Dr. Kimryn Rathmell serves as the director of the National Cancer Institute.
She is a distinguished leader and researcher in the field of kidney cancer. Specializing in the research and treatment of complex and hereditary kidney cancers.
She has held leadership positions with organizations such as the American Society of Clinical Oncology and the American Society for Clinical Investigation, she has been elected to esteemed academies including the Association of American Physicians, the American Academy of Arts and Sciences, and the National Academy of Medicine.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023